SWOG clinical trial number
CTSU/A221405
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer who Desire Pregnancy
Closed
Phase
Abbreviated Title
Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Women with Endocrine Responsive BC
Activated
10/15/2015
Closed
12/31/2019
Participants
ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS LISTED ON TITLE PAGE
Research committees
Breast Cancer
Cancer Survivorship
Eligibility Criteria Expand/Collapse
Eligibility criteria are accessible from the protocol abstract page on the CTSU website (http://www.ctsu.org).
Publication Information Expand/Collapse
2023
Interrupting Endocrine Therapy to Attempt Pregnancy After Breast Cancer
PMid: PMID37133584 | PMC number: PMC10358451
Other Clinical Trials
SWOG Clinical Trial Number
S1501
Prospective Evaluation of Carvedilol vs No treatment in Prevention of Cardiac Dysfunction in Patients with Metastatic HER-2+ Breast Cancer.
Research Committee(s)
Cancer Survivorship
Breast Cancer
Activated
09/15/2017
Accrual
37%
Open
Phase